{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:34:25Z","timestamp":1775561665350,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T00:00:00Z","timestamp":1541376000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11926-018-0789-2","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T06:39:17Z","timestamp":1541399957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Chronic Periaortitis: an Update"],"prefix":"10.1007","volume":"20","author":[{"given":"Alessandra","family":"Palmisano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Maritati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto","family":"Vaglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,5]]},"reference":[{"issue":"9506","key":"789_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(06)68035-5","volume":"367","author":"A Vaglio","year":"2006","unstructured":"Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006;367(9506):241\u201351.","journal-title":"Lancet"},{"issue":"5","key":"789_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1365-2559.1990.tb01541.x","volume":"16","author":"DV Parums","year":"1990","unstructured":"Parums DV. The spectrum of chronic periaortitis. Histopathology. 1990;16(5):423\u201331.","journal-title":"Histopathology"},{"key":"789_CR3","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Palmisano, A., et al., Chronic periaortitis with thoracic aorta and epiaortic artery involvement: a systemic large vessel vasculitis? Rheumatology (Oxford), 2015. The first study to identify and characterise the subset of patients with chronic periaortitis also involving the thoracic aorta.","DOI":"10.1093\/rheumatology\/kev225"},{"issue":"8","key":"789_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/jcp.23.8.681","volume":"23","author":"MJ Mitchinson","year":"1970","unstructured":"Mitchinson MJ. The pathology of idiopathic retroperitoneal fibrosis. J Clin Pathol. 1970;23(8):681\u20139.","journal-title":"J Clin Pathol"},{"issue":"3","key":"789_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.berh.2008.12.002","volume":"23","author":"A Palmisano","year":"2009","unstructured":"Palmisano A, Vaglio A. Chronic periaortitis: a fibro-inflammatory disorder. Best Pract Res Clin Rheumatol. 2009;23(3):339\u201353.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"7","key":"789_CR6","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1681\/ASN.2015101110","volume":"27","author":"A Vaglio","year":"2016","unstructured":"Vaglio A, Maritati F. Idiopathic retroperitoneal fibrosis. J Am Soc Nephrol. 2016;27(7):1880\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"789_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.autrev.2014.08.006","volume":"14","author":"G Ceresini","year":"2015","unstructured":"\u2022 Ceresini G, et al. Association between idiopathic retroperitoneal fibrosis and autoimmune thyroiditis: a case-control study. Autoimmun Rev. 2015;14(1):16\u201322 The first case-control study showing an association between chronic periaortitis and an autoimmune disease, namely Hashimoto\u2019s thyroiditis.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"789_CR8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.5414\/CNP74485","volume":"74","author":"A Palmisano","year":"2010","unstructured":"Palmisano A, Corradi D, Carnevali ML, Alberici F, Silini EM, Gatti R, et al. Chronic periaortitis associated with membranous nephropathy: clues to common pathogenetic mechanisms. Clin Nephrol. 2010;74(6):485\u201390.","journal-title":"Clin Nephrol"},{"key":"789_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1146\/annurev-pathol-012513-104708","volume":"9","author":"VS Mahajan","year":"2014","unstructured":"Mahajan VS, Mattoo H, Deshpande V, Pillai SS, Stone JH. IgG4-related disease. Annu Rev Pathol. 2014;9:315\u201347.","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"789_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4065\/mcp.2010.0663","volume":"86","author":"TA Kermani","year":"2011","unstructured":"Kermani TA, Crowson CS, Achenbach SJ, Luthra HS. Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc. 2011;86(4):297\u2013303.","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"789_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MD.0b013e3181afc420","volume":"88","author":"EF Bommel van","year":"2009","unstructured":"van Bommel EF, et al. Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine (Baltimore). 2009;88(4):193\u2013201.","journal-title":"Medicine (Baltimore)"},{"issue":"9788","key":"789_CR12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S0140-6736(11)60934-3","volume":"378","author":"A Vaglio","year":"2011","unstructured":"Vaglio A, Palmisano A, Alberici F, Maggiore U, Ferretti S, Cobelli R, et al. Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet. 2011;378(9788):338\u201346.","journal-title":"Lancet"},{"issue":"2","key":"789_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.rdc.2013.02.004","volume":"39","author":"PJ Scheel Jr","year":"2013","unstructured":"Scheel PJ Jr, Feeley N. Retroperitoneal fibrosis. Rheum Dis Clin N Am. 2013;39(2):365\u201381.","journal-title":"Rheum Dis Clin N Am"},{"issue":"2","key":"789_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.urology.2009.02.052","volume":"74","author":"A Palmisano","year":"2009","unstructured":"Palmisano A, Cobelli R, Buzio C, Vaglio A. Peri-renal collateral circles. Urology. 2009;74(2):292\u20133.","journal-title":"Urology"},{"issue":"7","key":"789_CR15","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1093\/ndt\/gfr779","volume":"27","author":"LG Pelkmans","year":"2012","unstructured":"Pelkmans LG, Aarnoudse AJLH, Hendriksz TR, van Bommel EFH. Value of acute-phase reactants in monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Nephrol Dial Transplant. 2012;27(7):2819\u201325.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"789_CR16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/MD.0b013e3181afc439","volume":"88","author":"PJ Scheel Jr","year":"2009","unstructured":"Scheel PJ Jr, Feeley N. Retroperitoneal fibrosis: the clinical, laboratory, and radiographic presentation. Medicine (Baltimore). 2009;88(4):202\u20137.","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"789_CR17","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.autrev.2006.03.011","volume":"5","author":"A Vaglio","year":"2006","unstructured":"Vaglio A, Greco P, Corradi D, Palmisano A, Martorana D, Ronda N, et al. Autoimmune aspects of chronic periaortitis. Autoimmun Rev. 2006;5(7):458\u201364.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"789_CR18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMra1104650","volume":"366","author":"JH Stone","year":"2012","unstructured":"Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366(6):539\u201351.","journal-title":"N Engl J Med"},{"issue":"12","key":"789_CR19","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1097\/PAS.0b013e3181b72882","volume":"33","author":"Y Zen","year":"2009","unstructured":"Zen Y, Onodera M, Inoue D, Kitao A, Matsui O, Nohara T, et al. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol. 2009;33(12):1833\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"789_CR20","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/ard.2011.155382","volume":"71","author":"A Vaglio","year":"2012","unstructured":"Vaglio A, Strehl JD, Manger B, Maritati F, Alberici F, Beyer C, et al. IgG4 immune response in Churg-Strauss syndrome. Ann Rheum Dis. 2012;71(3):390\u20133.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"789_CR21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3109\/s10165-011-0532-6","volume":"22","author":"M Yamamoto","year":"2012","unstructured":"Yamamoto M, Tabeya T, Naishiro Y, Yajima H, Ishigami K, Shimizu Y, et al. Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases. Mod Rheumatol. 2012;22(3):419\u201325.","journal-title":"Mod Rheumatol"},{"issue":"6","key":"789_CR22","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/sj.ki.5002427","volume":"72","author":"D Corradi","year":"2007","unstructured":"Corradi D, Maestri R, Palmisano A, Bosio S, Greco P, Manenti L, et al. Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int. 2007;72(6):742\u201353.","journal-title":"Kidney Int"},{"issue":"4","key":"789_CR23","first-page":"383","volume":"114","author":"DV Parums","year":"1990","unstructured":"Parums DV, Brown DL, Mitchinson MJ. Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. Arch Pathol Lab Med. 1990;114(4):383\u20137.","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"789_CR24","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.rdc.2007.07.013","volume":"33","author":"A Vaglio","year":"2007","unstructured":"Vaglio A, Palmisano A, Corradi D, Salvarani C, Buzio C. Retroperitoneal fibrosis: evolving concepts. Rheum Dis Clin N Am. 2007;33(4):803\u201317 vi-vii.","journal-title":"Rheum Dis Clin N Am"},{"issue":"1","key":"789_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/BOR.0b013e328341137d","volume":"23","author":"A Vaglio","year":"2011","unstructured":"Vaglio A, Pipitone N, Salvarani C. Chronic periaortitis: a large-vessel vasculitis? Curr Opin Rheumatol. 2011;23(1):1\u20136.","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"789_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.7326\/M13-2648","volume":"161","author":"M Goldoni","year":"2014","unstructured":"Goldoni M, Bonini S, Urban ML, Palmisano A, de Palma G, Galletti E, et al. Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis: a case-control study. Ann Intern Med. 2014;161(3):181\u20138.","journal-title":"Ann Intern Med"},{"issue":"7","key":"789_CR27","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1086\/433189","volume":"41","author":"P Greco","year":"2005","unstructured":"Greco P, Vaglio A, Corradi D, Cobelli R, Zompatori M, Buzio C. Tuberculosis as a trigger of retroperitoneal fibrosis. Clin Infect Dis. 2005;41(7):e72\u20135.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"789_CR28","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/art.21698","volume":"55","author":"D Martorana","year":"2006","unstructured":"Martorana D, Vaglio A, Greco P, Zanetti A, Moroni G, Salvarani C, et al. Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum. 2006;55(1):126\u201330.","journal-title":"Arthritis Rheum"},{"key":"789_CR29","unstructured":"\u2022\u2022 Martorana, D., et al., A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis. J Allergy Clin Immunol, 2018. The first large-scale genetic analysis, performed on a large cohort of patients, to show an association between chronic periaortitis and autoimmunity genetic markers such as the HLA-DRB1*03."},{"issue":"6","key":"789_CR30","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1093\/rheumatology\/keq416","volume":"50","author":"L Boiardi","year":"2011","unstructured":"Boiardi L, Vaglio A, Nicoli D, Farnetti E, Palmisano A, Pipitone N, et al. CC chemokine receptor 5 polymorphism in chronic periaortitis. Rheumatology (Oxford). 2011;50(6):1025\u201332.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"789_CR31","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/jcp.47.8.721","volume":"47","author":"AL Ramshaw","year":"1994","unstructured":"Ramshaw AL, Roskell DE, Parums DV. Cytokine gene expression in aortic adventitial inflammation associated with advanced atherosclerosis (chronic periaortitis). J Clin Pathol. 1994;47(8):721\u20137.","journal-title":"J Clin Pathol"},{"issue":"7","key":"789_CR32","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1136\/annrheumdis-2011-201166","volume":"71","author":"F Maritati","year":"2012","unstructured":"Maritati F, Corradi D, Versari A, Casali M, Urban ML, Buzio C, et al. Rituximab therapy for chronic periaortitis. Ann Rheum Dis. 2012;71(7):1262\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"789_CR33","first-page":"776","volume":"30","author":"MG Catanoso","year":"2012","unstructured":"Catanoso MG, Spaggiari L, Magnani L, Pipitone N, Versari A, Boiardi L, et al. Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosis. Clin Exp Rheumatol. 2012;30(5):776\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"789_CR34","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1002\/art.38032","volume":"65","author":"A Vaglio","year":"2013","unstructured":"Vaglio A, Catanoso MG, Spaggiari L, Magnani L, Pipitone N, Macchioni P, et al. Interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis. Arthritis Rheum. 2013;65(9):2469\u201375.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"789_CR35","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/hep.21697","volume":"45","author":"Y Zen","year":"2007","unstructured":"Zen Y, Fujii T, Harada K, Kawano M, Yamada K, Takahira M, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology. 2007;45(6):1538\u201346.","journal-title":"Hepatology"},{"issue":"7","key":"789_CR36","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3899\/jrheum.111143","volume":"39","author":"F Kollert","year":"2012","unstructured":"Kollert F, et al. CCL18 -- potential biomarker of fibroinflammatory activity in chronic periaortitis. J Rheumatol. 2012;39(7):1407\u201312.","journal-title":"J Rheumatol"},{"issue":"10","key":"789_CR37","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1093\/ndt\/gfs408","volume":"27","author":"D Mangieri","year":"2012","unstructured":"Mangieri D, Corradi D, Martorana D, Malerba G, Palmisano A, Libri I, et al. Eotaxin\/CCL11 in idiopathic retroperitoneal fibrosis. Nephrol Dial Transplant. 2012;27(10):3875\u201384.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"789_CR38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/MD.0b013e318289610f","volume":"92","author":"A Khosroshahi","year":"2013","unstructured":"Khosroshahi A, Carruthers MN, Stone JH, Shinagare S, Sainani N, Hasserjian RP, et al. Rethinking Ormond\u2019s disease: \u201cidiopathic\u201d retroperitoneal fibrosis in the era of IgG4-related disease. Medicine (Baltimore). 2013;92(2):82\u201391.","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"789_CR39","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1089\/thy.2010.0453","volume":"21","author":"MM Fatourechi","year":"2011","unstructured":"Fatourechi MM, Hay ID, McIver B, Sebo TJ, Fatourechi V. Invasive fibrous thyroiditis (Riedel thyroiditis): the Mayo Clinic experience, 1976-2008. Thyroid. 2011;21(7):765\u201372.","journal-title":"Thyroid"},{"issue":"1","key":"789_CR40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/03009740802406187","volume":"38","author":"G Famularo","year":"2009","unstructured":"Famularo G, Palmisano A, Afeltra A, Buzzulini F, Versari A, Minisola G, et al. Retroperitoneal fibrosis associated with psoriasis: a case series. Scand J Rheumatol. 2009;38(1):68\u20139.","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"789_CR41","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/rheumatology\/kem328","volume":"47","author":"A Vaglio","year":"2008","unstructured":"Vaglio A, Palmisano A, Ferretti S, Alberici F, Casazza I, Salvarani C, et al. Peripheral inflammatory arthritis in patients with chronic periaortitis: report of five cases and review of the literature. Rheumatology (Oxford). 2008;47(3):315\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"789_CR42","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.autrev.2017.07.020","volume":"16","author":"FX Danlos","year":"2017","unstructured":"\u2022 Danlos FX, et al. Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome. Autoimmun Rev. 2017;16(10):1036\u201343 A multicentre European case series describing an overlap between ANCA-associated vasculitis syndromes and IgG4-related disease.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"789_CR43","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0033-8389(22)00700-X","volume":"34","author":"JJ Kottra","year":"1996","unstructured":"Kottra JJ, Dunnick NR. Retroperitoneal fibrosis. Radiol Clin N Am. 1996;34(6):1259\u201375.","journal-title":"Radiol Clin N Am"},{"issue":"2","key":"789_CR44","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1148\/radiol.14131565","volume":"272","author":"B Bakir","year":"2014","unstructured":"Bakir B, Yilmaz F, Turkay R, \u00d6zel S, Bilgi\u00e7 B, Velioglu A, et al. Role of diffusion-weighted MR imaging in the differentiation of benign retroperitoneal fibrosis from malignant neoplasm: preliminary study. Radiology. 2014;272(2):438\u201345.","journal-title":"Radiology"},{"issue":"5","key":"789_CR45","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/MD.0b013e31826b1c1d","volume":"91","author":"T Mirault","year":"2012","unstructured":"Mirault T, Lambert M, Puech P, Argatu D, Renaud A, Duhamel A, et al. Malignant retroperitoneal fibrosis: MRI characteristics in 50 patients. Medicine (Baltimore). 2012;91(5):242\u201350.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"789_CR46","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/art.20914","volume":"53","author":"A Vaglio","year":"2005","unstructured":"Vaglio A, et al. (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis. Arthritis Rheum. 2005;53(1):122\u20135.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"789_CR47","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ejim.2010.02.008","volume":"21","author":"I Jansen","year":"2010","unstructured":"Jansen I, Hendriksz TR, Han SH, Huiskes AWLC, van Bommel EFH. (18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Eur J Intern Med. 2010;21(3):216\u201321.","journal-title":"Eur J Intern Med"},{"issue":"2","key":"789_CR48","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/art.21074","volume":"53","author":"C Salvarani","year":"2005","unstructured":"Salvarani C. Positron emission tomography (PET): evaluation of chronic periaortitis. Arthritis Rheum. 2005;53(2):298\u2013303.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"789_CR49","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.eururo.2016.10.046","volume":"71","author":"A Fernando","year":"2017","unstructured":"\u2022 Fernando A, et al. [(18)F]-fluorodeoxyglucose positron emission tomography in the diagnosis, treatment stratification, and monitoring of patients with retroperitoneal fibrosis: a prospective clinical study. Eur Urol. 2017;71(6):926\u201333 An important study on the diagnostic and prognostic value of PET, showing that baseline PET results can inform on response to therapy.","journal-title":"Eur Urol"},{"issue":"1","key":"789_CR50","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.eururo.2017.09.024","volume":"73","author":"E Accorsi Buttini","year":"2018","unstructured":"\u2022 Accorsi Buttini E, Maritati F, Vaglio A. [(18)F]-Fluorodeoxyglucose positron emission tomography and response to therapy in idiopathic retroperitoneal fibrosis. Eur Urol. 2018;73(1):145\u20136 The largest study on the prognostic role of PET in chronic periaortitis.","journal-title":"Eur Urol"},{"issue":"4","key":"789_CR51","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1016\/j.urology.2013.01.004","volume":"81","author":"C Ellimoottil","year":"2013","unstructured":"Ellimoottil C, Hart S, Mehta V, Quek ML. Localized perirenal retroperitoneal fibrosis. Urology. 2013;81(4):e27\u20138.","journal-title":"Urology"},{"issue":"2","key":"789_CR52","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2214\/AJR.07.3629","volume":"191","author":"CG Cronin","year":"2008","unstructured":"Cronin CG, Lohan DG, Blake MA, Roche C, McCarthy P, Murphy JM. Retroperitoneal fibrosis: a review of clinical features and imaging findings. AJR Am J Roentgenol. 2008;191(2):423\u201331.","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"789_CR53","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1148\/rg.334125081","volume":"33","author":"V George","year":"2013","unstructured":"George V, Tammisetti VS, Surabhi VR, Shanbhogue AK. Chronic fibrosing conditions in abdominal imaging. Radiographics. 2013;33(4):1053\u201380.","journal-title":"Radiographics"},{"issue":"1 Suppl 64","key":"789_CR54","first-page":"S72","volume":"29","author":"N Pipitone","year":"2011","unstructured":"Pipitone N, Versari A, Vaglio A, Salvarani C. Role of 18F-fluorodeoxyglucose positron emission tomography in the workup of retroperitoneal fibrosis. Clin Exp Rheumatol. 2011;29(1 Suppl 64):S72\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"789_CR55","first-page":"294","volume":"29","author":"SE Akhan","year":"2008","unstructured":"Akhan SE, Dogan Y, Akhan S, Iyibozkurt AC, Topuz S, Yalcin O. Pelvic actinomycosis mimicking ovarian malignancy: three cases. Eur J Gynaecol Oncol. 2008;29(3):294\u20137.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"1","key":"789_CR56","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0002-8703(96)90074-5","volume":"131","author":"S Ahmad","year":"1996","unstructured":"Ahmad S. Association of metoprolol and retroperitoneal fibrosis. Am Heart J. 1996;131(1):202\u20133.","journal-title":"Am Heart J"},{"issue":"11","key":"789_CR57","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.3899\/jrheum.130324","volume":"40","author":"M Couderc","year":"2013","unstructured":"Couderc M, et al. Retroperitoneal fibrosis during etanercept therapy for rheumatoid arthritis. J Rheumatol. 2013;40(11):1931\u20133.","journal-title":"J Rheumatol"},{"issue":"1","key":"789_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.revmed.2014.10.008","volume":"36","author":"ML Urban","year":"2015","unstructured":"Urban ML, Palmisano A, Nicastro M, Corradi D, Buzio C, Vaglio A. Idiopathic and secondary forms of retroperitoneal fibrosis: a diagnostic approach. Rev Med Interne. 2015;36(1):15\u201321.","journal-title":"Rev Med Interne"},{"issue":"4","key":"789_CR59","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","volume":"124","author":"EL Diamond","year":"2014","unstructured":"Diamond EL, Dagna L, Hyman DM, Cavalli G, Janku F, Estrada-Veras J, et al. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood. 2014;124(4):483\u201392.","journal-title":"Blood"},{"issue":"3","key":"789_CR60","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/iju.12234","volume":"21","author":"S Mertens","year":"2014","unstructured":"Mertens S, Zeegers AGM, Wertheimer PA, Hendriksz TR, van Bommel EFH. Efficacy and complications of urinary drainage procedures in idiopathic retroperitoneal fibrosis complicated by extrinsic ureteral obstruction. Int J Urol. 2014;21(3):283\u20138.","journal-title":"Int J Urol"},{"issue":"5","key":"789_CR61","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1053\/j.ajkd.2007.02.268","volume":"49","author":"EF Bommel van","year":"2007","unstructured":"van Bommel EF, et al. Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis. 2007;49(5):615\u201325.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"789_CR62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.7326\/0003-4819-154-1-201101040-00005","volume":"154","author":"PJ Scheel Jr","year":"2011","unstructured":"Scheel PJ Jr, Feeley N, Sozio SM. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case series. Ann Intern Med. 2011;154(1):31\u20136.","journal-title":"Ann Intern Med"},{"issue":"4","key":"789_CR63","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/rheumatology\/kel417","volume":"46","author":"RN Jois","year":"2007","unstructured":"Jois RN, Kerrigan N, Scott DG. Mycophenolate mofetil for maintenance of remission in idiopathic retroperitoneal fibrosis. Rheumatology (Oxford). 2007;46(4):717\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"789_CR64","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/annrheumdis-2011-200148","volume":"71","author":"M Binder","year":"2012","unstructured":"Binder M, Uhl M, Wiech T, Kollert F, Thiel J, Sass JO, et al. Cyclophosphamide is a highly effective and safe induction therapy in chronic periaortitis: a long-term follow-up of 35 patients with chronic periaortitis. Ann Rheum Dis. 2012;71(2):311\u20132.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"789_CR65","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.amjmed.2003.08.033","volume":"116","author":"R Marcolongo","year":"2004","unstructured":"Marcolongo R, Tavolini IM, Laveder F, Busa M, Noventa F, Bassi P, et al. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. Am J Med. 2004;116(3):194\u20137.","journal-title":"Am J Med"},{"issue":"9","key":"789_CR66","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1136\/annrheumdis-2013-203267","volume":"72","author":"F Alberici","year":"2013","unstructured":"Alberici F, Palmisano A, Urban ML, Maritati F, Oliva E, Manenti L, et al. Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis. Ann Rheum Dis. 2013;72(9):1584\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"789_CR67","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015;74(6):1171\u20137.","journal-title":"Ann Rheum Dis"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-018-0789-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-018-0789-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-018-0789-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T05:56:48Z","timestamp":1662357408000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-018-0789-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,5]]},"references-count":67,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["789"],"URL":"https:\/\/doi.org\/10.1007\/s11926-018-0789-2","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,5]]},"assertion":[{"value":"5 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"80"}}